HIGHLIGHTS
- who: Athénaï from the Department of Radiation Oncology, University Hospital of Besançon, Besançon, France, Department of Statistics, Centre have published the Article: Long-Term Disease Control After locoregional Pelvic Chemoradiation in Patients with Advanced Anal Squamous Cell Carcinoma, in the Journal: (JOURNAL) of 12/04/2022
- what: The authors reported the efficacy and safety of standard CRT in patients with advanced SCCA at diagnosis, who had a significant objective response after DCF as the first line treatment. The aims were to evaluate the safety and local efficacy of CRT. The main . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.